EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review

Gaurav Singhal iD, Saurabh Singhal, Bernhard T Baune

Neuroprotection · 2025-09 · 3 (3) · 206-225

DOI: 10.1002/nep3.70009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuroprotection, online erschienen am 06.06.2025. Verfasst von Gaurav Singhal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology, Department of Surgery University of Wisconsin Madison Wisconsin USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is a complex psychiatric condition increasingly linked to chronic neuroinflammation, particularly in the context of aging, stress, and systemic comorbidities. While microglia have traditionally been the focus of neuroimmune studies, growing evidence highlights astrocytes as central regulators in the pathogenesis of MDD. This review synthesizes current findings on the multifaceted roles of astrocytes in neuroplasticity, neurotransmission, metabolic support, and blood‐brain barrier regulation. It explores how astrocyte reactivity and the release of pro‐inflammatory cytokines are often triggered by psychosocial stress, aging, and peripheral immune activation and contribute to synaptic dysfunction and cognitive impairment. The review also examines the bidirectional crosstalk between astrocytes and microglia, astrocytic calcium signaling, epigenetic modulation via histone lactylation, and metabolic pathways involving lactate. Special attention is given to the region‐specific and phenotype‐dependent responses of astrocytes, as well as their influence on the onset and maintenance of depressive symptoms. Additionally, therapeutic strategies targeting astrocyte‐mediated pathways, including anti‐inflammatory agents, metabolic modulators, repetitive transcranial magnetic stimulation, and inflammasome inhibitors, are discussed. Finally, methodological challenges and future research directions are outlined, emphasizing the need for precision medicine approaches in developing astrocyte‐targeted interventions for MDD.

Schlagwörter

Stichwörter der Autor:innen

agingastrocytesdepressionneuroinflammationneuroplasticityneuroprotection

Autor:innen und Institutionen

  • Division of Otolaryngology, Department of Surgery University of Wisconsin Madison Wisconsin USA.
  • Center of Liver-GI Diseases and Transplantation Akash Healthcare Superspeciality Hospital New Delhi New Delhi India.
  • Department of Psychiatry University of Münster Münster Germany.
  • Department of Psychiatry University of Melbourne Melbourne Victoria Australia.

ORCID-Profile: Gaurav Singhal

Zitieren

APA

Singhal, G., Singhal, S., & Baune, B. T. (2025). Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review. Neuroprotection, 3(3), 206-225. https://doi.org/10.1002/nep3.70009

Vancouver

Singhal G, Singhal S, Baune BT. Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review. Neuroprotection. 2025;3(3):206-225. doi:10.1002/nep3.70009

BibTeX
@article{Singhal2025,
  author = {Singhal, Gaurav and Singhal, Saurabh and Baune, Bernhard T},
  title = {Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review},
  journal = {Neuroprotection},
  year = {2025},
  volume = {3},
  number = {3},
  pages = {206--225},
  doi = {10.1002/nep3.70009}
}
Kostenlos starten →